[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Lin et al., 2014 - Google Patents

Preparation, characterization, and evaluation of dipfluzine–benzoic acid co-crystals with improved physicochemical properties

Lin et al., 2014

Document ID
14499885937046237428
Author
Lin Y
Yang H
Yang C
Wang J
Publication year
Publication venue
Pharmaceutical research

External Links

Snippet

Purpose To prepare and characterize the co-crystal of dipfluzine and benzoic acid. To investigate the feasibility of the co-crystal for improving solubility and a faster dissolution rate in vitro and evaluate the bioavailability and tissue distribution of co-crystal in vivo. Methods A …
Continue reading at link.springer.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings

Similar Documents

Publication Publication Date Title
Lin et al. Preparation, characterization, and evaluation of dipfluzine–benzoic acid co-crystals with improved physicochemical properties
Shayanfar et al. Drug–drug coamorphous systems: characterization and physicochemical properties of coamorphous atorvastatin with carvedilol and glibenclamide
Patel et al. Preparation, structural analysis, and properties of tenoxicam cocrystals
Skorupska et al. Thermal solvent-free method of loading of pharmaceutical cocrystals into the pores of silica particles: A Case of naproxen/picolinamide cocrystal
Golob et al. Improving biopharmaceutical properties of vinpocetine through cocrystallization
Limwikrant et al. Formation mechanism of a new carbamazepine/malonic acid cocrystal polymorph
Zhu et al. Stable cocrystals and salts of the antineoplastic drug apatinib with improved solubility in aqueous solution
Ross et al. Coprocessing of pharmaceutical cocrystals for high quality and enhanced physicochemical stability
CN109734690A (en) New ABEXINOSTATE salt, relevant crystal form, preparation method and the pharmaceutical composition containing it
Roumeli et al. Compatibility study between trandolapril and natural excipients used in solid dosage forms
Ma et al. The delivery of triamterene by cucurbit [7] uril: synthesis, structures and pharmacokinetics study
Singh et al. Characterization of solid state forms of glipizide
Wang et al. Drug-drug cocrystals of theophylline with quercetin
Spinelli et al. Molecular salts of the antidepressant venlafaxine: an effective route to solubility properties modifications
Detrich et al. Polymorphic forms of bisoprolol fumarate: Preparation and characterization
Bruni et al. Multicomponent crystals of gliclazide and tromethamine: preparation, physico-chemical, and pharmaceutical characterization
Shi et al. Improving physicochemical properties of Ibrutinib with cocrystal strategy based on structures and natures of the carboxylic acid co-formers
Shi et al. Improving the Solubility and Dissolution of Ibrutinib by preparing Solvates
Budiman et al. Drug-Coformer Loaded-Mesoporous Silica Nanoparticles: A Review of the Preparation, Characterization, and Mechanism of Drug Release
Wang et al. Solid-state characterization of 17β-estradiol co-crystals presenting improved dissolution and bioavailability
Lian et al. Crystal engineering approach to produce complex of azelnidipine with maleic acid
CN111819174A (en) Polymorphs and solid forms of pyrimidinylamino-pyrazole compounds and methods of preparation
Blokhina et al. New diclofenac choline hydrate salt: Synthesis, characterization and solubility
WO2022171117A1 (en) Salt of nitrogen-containing fused heterocyclic compound or crystal form thereof, and preparation method therefor, pharmaceutical composition thereof, and use thereof
Li et al. Synthesis and characterization of supramolecular assembly probenecid cocrystal